Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax to Participate in Multiple Investor Conferences in September
- Corporate and Finance
Sep 2, 2015
Novavax to Host 3rd Annual Analyst and Investor Meeting
- Corporate and Finance
Aug 26, 2015
Novavax Reports Second Quarter 2015 Financial Results
- Corporate and Finance
Aug 10, 2015
Novavax Announces Positive Top-Line Data from Phase 2 RSV F-Protein Vaccine Clinical Trial in Older Adults
- RSV
Aug 10, 2015
Novavax to Present at the Wedbush PacGrow Healthcare Conference
- Corporate and Finance
Aug 5, 2015
Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 10, 2015
- Corporate and Finance
Aug 3, 2015
Novavax Announces Positive Data From Phase 2 Trial of Quadrivalent Seasonal Influenza VLP
- Seasonal Influenza
Jul 30, 2015
Novavax Announces Positive Top-Line Data From Phase 1 Ebola Vaccine Trial on WHO Teleconference
- Ebola
Jul 21, 2015
Novavax Recognized by Washington Post as Top Workplace
- Corporate and Finance
Jun 19, 2015
Novavax Appoints Gail Boudreaux to Board
- Corporate and Finance
Jun 18, 2015
Novavax Announces Management Promotion
- Corporate and Finance
Jun 15, 2015
Novavax Reports First Quarter 2015 Financial Results
- Corporate and Finance
May 7, 2015
Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 7, 2015
- Corporate and Finance
Apr 30, 2015
Novavax to Present at the 14th Annual Needham Healthcare Conference
- Corporate and Finance
Apr 8, 2015
Novavax Announces Closing of Public Offering
- Corporate and Finance
Mar 31, 2015
Novavax Presents New Data From Non-Human Primate Ebola Challenge at the 7th International Symposium on Filoviruses
- Ebola
Mar 28, 2015
Novavax Prices Public Offering of Common Stock
- Corporate and Finance
Mar 26, 2015
Novavax Announces Proposed Public Offering of Common Stock
- Corporate and Finance
Mar 24, 2015
Novavax Appoints Brian Rosen as Vice President, Government Affairs
- Corporate and Finance
Mar 10, 2015
Novavax Reports Fourth Quarter and Year-End 2014 Financial Results
- Corporate and Finance
Feb 26, 2015
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015
- Corporate and Finance
Feb 19, 2015
Novavax Announces Initiation of Ebola Vaccine Phase 1 Clinical Trial Supported by Non-Human Primate Challenge Data and Documented Rapid Manufacturing Capabilities
- Ebola
Feb 12, 2015
Novavax Announces Management Promotion
- Corporate and Finance
Jan 8, 2015
Novavax to Present at the 33rd Annual J.P. Morgan Healthcare Conference
- Corporate and Finance
Jan 7, 2015

Show per page